INTRODUCTION AND HYPOTHESIS: This is an observational multicentre prospective study into the complications and effectiveness of TVT SECUR™. METHODS: One hundred forty-seven patients with urodynamic or occult Stress Urinary Incontinence (SUI) were enrolled. Outcome measures at 6, 12 and 24 months were: objective cough test; subjective responses to PGI-S questionnaire and Visual Analogue Score. STATISTICAL ANALYSIS: Wilcoxon Test; Monte Carlo Exact Test. RESULTS: Ninety-five urodynamic SUI and 41 occult SUI patients were treated using transobturator (H-position) or retropubic (U-position) approach (110 vs. 26 patients). Cure rates at 6, 12, and 24 months were 87.5%, 88.6% and 89.5%. Failure rates at all follow-ups were similar for urodynamic and occult SUI. The U-position failure rate was comparable to H-position at short-term but significantly higher at mid-term. Familiarity with the technique brought significantly higher success rates. CONCLUSIONS: TVT SECUR is safe, effective and versatile, but has an appreciable learning curve.
INTRODUCTION AND HYPOTHESIS: This is an observational multicentre prospective study into the complications and effectiveness of TVT SECUR™. METHODS: One hundred forty-seven patients with urodynamic or occult Stress Urinary Incontinence (SUI) were enrolled. Outcome measures at 6, 12 and 24 months were: objective cough test; subjective responses to PGI-S questionnaire and Visual Analogue Score. STATISTICAL ANALYSIS: Wilcoxon Test; Monte Carlo Exact Test. RESULTS: Ninety-five urodynamic SUI and 41 occult SUI patients were treated using transobturator (H-position) or retropubic (U-position) approach (110 vs. 26 patients). Cure rates at 6, 12, and 24 months were 87.5%, 88.6% and 89.5%. Failure rates at all follow-ups were similar for urodynamic and occult SUI. The U-position failure rate was comparable to H-position at short-term but significantly higher at mid-term. Familiarity with the technique brought significantly higher success rates. CONCLUSIONS:TVT SECUR is safe, effective and versatile, but has an appreciable learning curve.
Authors: Thierry Roumeguère; Th Quackels; R Bollens; A de Groote; A Zlotta; M Vanden Bossche; C Schulman Journal: Eur Urol Date: 2005-08-31 Impact factor: 20.096
Authors: P Costa; P Grise; S Droupy; F Monneins; C Assenmacher; P Ballanger; J F Hermieu; V Delmas; L Boccon-Gibod; C Ortuno Journal: Eur Urol Date: 2004-07 Impact factor: 20.096
Authors: Yun Peng; Rose Khavari; Nissrine A Nakib; Julie N Stewart; Timothy B Boone; Yingchun Zhang Journal: J Biomech Eng Date: 2015-07-14 Impact factor: 2.097
Authors: Ana Maria H M Bianchi-Ferraro; Zsuzsanna I K Jarmy-Di Bella; Rodrigo de A Castro; Maria Augusta T Bortolini; Marair G F Sartori; Manoel J B C Girão Journal: Int Urogynecol J Date: 2012-12-04 Impact factor: 2.894
Authors: Ana Maria H M Bianchi-Ferraro; Zsuzsanna I K Jarmy-DiBella; Rodrigo de Aquino Castro; Maria Augusta T Bortolini; Marair G F Sartori; Manoel J B C Girão Journal: Int Urogynecol J Date: 2014-03-19 Impact factor: 2.894
Authors: Sue Ross; Selphee Tang; Jane Schulz; Magnus Murphy; Jose Goncalves; Stephen Kaye; Lorel Dederer; Magali Robert Journal: BMC Res Notes Date: 2014-12-22